Please login to the form below

Not currently logged in


This page shows the latest Saxenda news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk fends off Lilly’s GLP-1 challenge in Q1

Novo Nordisk fends off Lilly’s GLP-1 challenge in Q1

The company is already creating a market-leading presence in obesity treatment: its injectable Saxenda (a version of liraglutide aka Victoza), saw sales rise 43% in the first three months of

Latest news

More from news
Approximately 7 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
GK Strategy

GK is award-winning independent communications agency specialising in delivering impactful strategies for clients across the healthcare market....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....